Contact UsTwo Pershing Square 2300 Main Street, Suite 170 Kansas City MO 64108
Two Pershing Square
2300 Main Street, Suite 170
Kansas City, MO 64108
An FDA Safety Communication has been issued regarding the recall of Exactech hip, knee, and ankle implants. The recall, which began in the summer of 2021 with hip replacement devices, expanded to include many knee and ankle implants as well.
Exactech’s recalled devices have polyethylene inserts that wear too early, cause pain and can lead to the need for revision surgery.
Exactech recall lawsuits are moving forward in both Florida state courts and federal courts. The first cases were filed in the Florida state court in Gainesville, FL and the first trial for these state cases has been set for November 2023.
Questions? Call us at (877) 284-6600.
The first trial date has been set for Exactech consolidated hip, knee, and ankle lawsuits in the Eighth Judicial Circuit of Florida for November 6, 2023. The Hon. Donna Keim has prioritized moving this docket along quickly. Setting the first trial date for a little more than a year from now demonstrates her commitment to this goal.
Brian Franciskato, trial lawyer and partner, has been named a member of the Plaintiff Steering Committee for the consolidated Exactech lawsuits in Florida’s Eighth Judicial Circuit for recalled hip, knee and ankle implants.
In June of this year, Philips Respironics announced a voluntary recall of several models of its CPAP, BiPAP, and other ventilator devices. With 93 proposed class-action lawsuits being filed by the end of September, a request was made to consolidate all claims before one judge for coordinated management as part of a multidistrict litigation. (MDL).
The Judicial Panel of Multidistrict Litigation (JPML) recently heard arguments concerning an MDL. The outcome? Due to the similarity of the claims, the JPML granted motions to consolidate the pretrial proceedings. As of October 8, 2021, there were more than 100 lawsuits filed against Philips.
As of June 28, 2021, there were 90 paraquat herbicide lawsuits that had been filed across the country with claims related to exposure to paraquat.
In February 2020, the U.S. Judicial Panel on Multidistrict Litigation consolidated all of the Zantac lawsuits in the U.S. District Court for the Southern District of Florida under Judge Robin Rosenberg.
Over the next two years, St. Louis will be the place for numerous lawsuits filed against Johnson & Johnson alleging the use of talcum-powder based products manufactured and sold by the company caused ovarian cancer.
Having St. Louis be a hub for these trials was in jeopardy after a U.S. Supreme Court ruling in June severely restricted jurisdiction in litigation, primarily to the states in which the defendants are based or where the injured parties lived.
A growing number of Proton Pump Inhibitor (PPI) lawsuits have been filed against the manufacturers of PPI medications. Plaintiffs allege that as a result of taking a PPI for gastric acid-related conditions, they have been diagnosed with kidney injuries including Acute Interstitial Nephritis (AIN), chronic kidney disease and renal failure.
Originally scheduled to start in February, the first Bellwether trial for the blood thinner, Xarelto, will now begin on April 24, 2017 in the Eastern District of Louisiana.